This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
Aug. 19, 2011 /PRNewswire/ -- Tibet Pharmaceuticals, Inc. (NASDAQ: TBET), an emerging specialty pharmaceutical company engaged in the development, manufacturing and marketing of traditional Tibetan medicine in
China, today announced the availability of the transcript for its second quarter 2011 earnings conference call, held on
During the conference call
Sally He, Tibet Pharmaceutical's VP and Assistant to the Chairman, stated, "As evidenced by our numbers this year, Tibet Pharmaceuticals has positioned itself to take full advantage of the favorable market conditions in
Summary of Second Quarter 2011 Financial Results:
Revenue of $8.7 million, an increase of 12% from $7.8 million in Q2 2010
Net income of $3.5 million compared to $3.4 million in Q2 2010
Fully diluted EPS of $0.25
Ms. He continued, "As we move into the third quarter of 2011, we expect to further increase awareness of our top selling traditional Tibetan medicines, with a particular focus on organic growth and accretive acquisitions."
Throughout the conference call Tibet's management talked about the company's portfolio of traditional Tibetan medicine products, its operations and production capacity and full details surrounding its revenue and earnings numbers for the second quarter ended
June 30, 2011 and the first half of fiscal 2011.
Interested parties are encouraged to read the full transcript of the conference call, which is available here:
http://www.trilogy-capital.com/autoir/tbet_autoir.htmlAbout Tibet Pharmaceuticals, Inc.
Based in Shangri-La County,
China, Tibet Pharmaceuticals, Inc. (NASDAQ: TBET) is a rapidly growing specialty pharmaceutical company engaged in the research, development, manufacturing and marketing of modernized traditional Tibetan medicines in
China. With over 190 employees and nation-wide distributors, the company develops both prescription and over-the-counter traditional Tibetan medicines that promote health in human respiratory, digestive, urinary and reproductive systems. Tibet Pharmaceuticals' products are sold throughout
China, with a majority of sales concentrated in the southern provinces, most notably
Yunnan Province, where the company's 52,000 sq. ft. GMP-certified manufacturing facilities are located. The access to key raw materials, not generally available outside the province, provides a significant advantage for Tibet Pharmaceuticals.
For comprehensive investor relations material, including fact sheets, research reports, presentations and video, please follow the appropriate link:
Investor Portal and
For more information on Tibet Pharmaceuticals, please visit: